| Brandy Nichole Jones, LICSW | |
|
635 W College St, Florence, AL 35630-5313 | |
| (256) 764-3431 | |
| (256) 768-7462 |
| Full Name | Brandy Nichole Jones |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 15 Years |
| Location | 635 W College St, Florence, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235697020 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4122C (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Behavioral Health, Inc | 7416194113 | 75 |
| Russellville Hospital Inc. | 3476878489 | 83 |
| Integrated Behavioral Health, Inc | 7416194113 | 75 |
News Archive
A phenomenological study offers detailed insights into homeless, alcohol-dependent patients often stigmatized by the public and policymakers as drains on the health care system, showing the constellation of reasons they are incapable of escaping social circumstances that perpetuate and exacerbate their problems.
Are you a female athlete - or just someone who likes challenging workouts - who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
› Verified 9 days ago
| Entity Name | Riverbend Center For Mental Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508822313 PECOS PAC ID: 6507821048 Enrollment ID: O20041124000245 |
News Archive
A phenomenological study offers detailed insights into homeless, alcohol-dependent patients often stigmatized by the public and policymakers as drains on the health care system, showing the constellation of reasons they are incapable of escaping social circumstances that perpetuate and exacerbate their problems.
Are you a female athlete - or just someone who likes challenging workouts - who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
› Verified 9 days ago
| Entity Name | Integrated Behavioral Health, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730522699 PECOS PAC ID: 7416194113 Enrollment ID: O20131007001029 |
News Archive
A phenomenological study offers detailed insights into homeless, alcohol-dependent patients often stigmatized by the public and policymakers as drains on the health care system, showing the constellation of reasons they are incapable of escaping social circumstances that perpetuate and exacerbate their problems.
Are you a female athlete - or just someone who likes challenging workouts - who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
› Verified 9 days ago
| Entity Name | Russellville Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780232314 PECOS PAC ID: 3476878489 Enrollment ID: O20191018002761 |
News Archive
A phenomenological study offers detailed insights into homeless, alcohol-dependent patients often stigmatized by the public and policymakers as drains on the health care system, showing the constellation of reasons they are incapable of escaping social circumstances that perpetuate and exacerbate their problems.
Are you a female athlete - or just someone who likes challenging workouts - who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandy Nichole Jones, LICSW 635 W College St, Florence, AL 35630-5313 Ph: (256) 764-3431 | Brandy Nichole Jones, LICSW 635 W College St, Florence, AL 35630-5313 Ph: (256) 764-3431 |
News Archive
A phenomenological study offers detailed insights into homeless, alcohol-dependent patients often stigmatized by the public and policymakers as drains on the health care system, showing the constellation of reasons they are incapable of escaping social circumstances that perpetuate and exacerbate their problems.
Are you a female athlete - or just someone who likes challenging workouts - who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Researchers have found long-sought genes in the sensory hair cells of the inner ear that, when mutated, prevent sound waves from being converted to electric signals - a fundamental first step in hearing. The team, co-led by Jeffrey Holt, PhD, in the department of otolaryngology at Children-s Hospital Boston, and Andrew Griffith, MD, PhD, of the NIH-s National Institute on Deafness and other Communication Disorders (NIDCD), then restored these electrical signals in the sensory cells of deaf mice by introducing normal genes.
› Verified 9 days ago
Kyle Smith, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 542 W Cleveland Ave, Florence, AL 35630 Phone: 256-762-3964 | |
Robert D Bucher, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-765-2036 | |
Julie F Dean, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-765-2036 | |
Wesley J. Puckett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-768-7462 | |
Candace Leigh Strait, L.C.S.W, PIP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-765-2036 | |
Terri Lynn Whalen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 635 W College St, Florence, AL 35630 Phone: 256-764-3431 Fax: 256-765-2036 |